Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Fox

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Parkinsonism & Related Disorders|June 22, 2014
Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesiasOlivier Rascol, Susan Fox, Fabrizio Gasparini, et al.
Lancet (London, England)|January 20, 2024
Medical, surgical, and physical treatments for Parkinson's diseaseTom Foltynie, Veronica Bruno, Susan Fox, et al.
International Review of Neurobiology|July 23, 2023
Advances in targeting neurotransmitter systems in dystoniaDora Steel, Kimberley M Reid, Antonio Pisani, et al.
Plos Genetics|January 14, 2012
A genetic screening strategy identifies novel regulators of the proteostasis networkM Catarina Silva, Susan Fox, Monica Beam, et al.
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|January 24, 2006
Caregiving by family and friends of adults receiving dialysisHeather Beanlands, Martha E Horsburgh, Susan Fox, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 11, 2004
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's diseaseSusan Fox, Montague Silverdale, Mark Kellett, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 5, 2023
The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial ExperienceBlas Couto, Susan Fox, Maria Carmela Tartaglia, et al.
BMJ Leader|November 12, 2024
Gender disparity in Canadian Institutes of Health Research funding within neurologyBrendan Tao, Chia-Chen Tsai, Catherine Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trialVera Hirsh, Jean Latreille, Harvey Kreisman, et al.
Annals of Neurology|March 28, 2012
Dihydropyridine calcium channel blockers and the progression of parkinsonismConnie Marras, Andrea Gruneir, Paula Rochon, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Parkinsonism & Related Disorders|June 22, 2014
Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesiasOlivier Rascol, Susan Fox, Fabrizio Gasparini, et al.
Lancet (London, England)|January 20, 2024
Medical, surgical, and physical treatments for Parkinson's diseaseTom Foltynie, Veronica Bruno, Susan Fox, et al.
International Review of Neurobiology|July 23, 2023
Advances in targeting neurotransmitter systems in dystoniaDora Steel, Kimberley M Reid, Antonio Pisani, et al.
Plos Genetics|January 14, 2012
A genetic screening strategy identifies novel regulators of the proteostasis networkM Catarina Silva, Susan Fox, Monica Beam, et al.
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|January 24, 2006
Caregiving by family and friends of adults receiving dialysisHeather Beanlands, Martha E Horsburgh, Susan Fox, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 11, 2004
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's diseaseSusan Fox, Montague Silverdale, Mark Kellett, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 5, 2023
The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial ExperienceBlas Couto, Susan Fox, Maria Carmela Tartaglia, et al.
BMJ Leader|November 12, 2024
Gender disparity in Canadian Institutes of Health Research funding within neurologyBrendan Tao, Chia-Chen Tsai, Catherine Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trialVera Hirsh, Jean Latreille, Harvey Kreisman, et al.
Annals of Neurology|March 28, 2012
Dihydropyridine calcium channel blockers and the progression of parkinsonismConnie Marras, Andrea Gruneir, Paula Rochon, et al.
Pageof 8